Chongqing Zhifei Biological Products Co
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
8/10
|
14.43 | 69.4 | -79.21% | 53.39 | -72.97% |
| P/S |
|
2.72 | 6.51 | -58.2% |
|
|
| P/BV |
|
4.09 | 3.96 | 3.38% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
12.21 | 11.85 | 3.05% |
|
|
| Ev/S |
|
2.68 | 5.98 | -55.16% |
|
|
| Ev/FCF |
|
0 | 0 | 0% |
|
|
| E/P |
|
0.0712 | 0.0396 | 79.82% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
22.61 | 20.39 | 10.9% | 27.01 | -16.27% |
| ROE |
|
33.36 | 11.95 | 179.27% |
|
|
| ROA |
|
14.93 | 5.4 | 176.39% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
18.84 | 16.23 | 16.06% |
|
|
| ROCE |
|
0 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.4455 | 14.63 | -96.95% | 0.2958 | +50.64% |
| Nеt Debt/Ebitda |
|
0 | 0 | 0% |
|
|
| Debt/Ratio |
|
0 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
0.5346 | 3.6 | -85.15% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
2.8/10
|
1.12 | 1.83 | -38.9% | 0.3566 | +214.08% |
| Number of years of dividend growth |
|
2 | 1.44 | 39.13% | ||
| DSI |
|
1 | 0.9113 | 9.73% |
|
|
| Average dividend growth |
|
34.18 | 10.4 | 228.76% |
|
|
| Average percentage for 5 years |
|
0.3566 | 1.14 | -68.78% |
|
|
| Average percentage for payments |
|
40.69 | 44.8 | -9.18% |
|
|
| Difference from average difference in sector |
|
-0.713 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
397.57 | 61.43 | 547.19% | ||
| Growth impulse Ebitda in 5 years |
|
216.32 | 158.62 | 36.38% | ||
| Growth impulse Net Income in 5 years |
|
241.01 | 66.93 | 260.09% | ||
| Growth impulse FCF in 5 years |
|
890.12 | 248.41 | 258.33% | ||
| Growth impulse EPS in 5 years |
|
155.75 | 73.29 | 112.51% |
IP Score
7.4/10
